This potentially enables cancer cells to thrive under stress when heightened mitochondrial function is necessary, and may explain the advantage Drp1(-/17) expression confers for in vivo tumor growth, compared to Drp1(16/17) (Figs. 5, 6). This evidence concerns the gene DNM1L and cancer.